Why We Need to Talk About Breast Implant Illness
Uncovering the hidden symptoms of breast implant illness and why women deserve answers, awareness, and action now.
Breast implant illness (BII) represents a complex and often overlooked health concern affecting women worldwide who have undergone breast augmentation or reconstruction. Characterized by a range of systemic symptoms including chronic
fatigue
,joint pain
,brain fog
, and more, BII has prompted thousands of women to share their stories online and seek explantation surgery. Despite growing patient reports, medical consensus remains elusive, underscoring the urgent need for open dialogue, rigorous research, and improved patient support.What is breast implant illness?
Breast implant illness refers to a variety of systemic symptoms reported by women following breast implant surgery, whether for cosmetic augmentation or post-mastectomy reconstruction. The U.S. Food and Drug Administration (FDA) acknowledges that patients and clinicians use the term “breast implant illness” or “BII” to describe these issues, which occur regardless of implant type—silicone or saline, textured or smooth. Symptoms can emerge immediately after implantation or years later, complicating diagnosis.
Health Canada similarly defines BII as various symptoms or diseases experienced by people with breast implants, unaffected by implant size, shape, fill type, or surface texture. Common theories include inflammatory responses to implant materials, bacterial biofilms, or autoimmune reactions like ASIA (Autoimmune/Inflammatory Syndrome Induced by Adjuvants), though causation remains unproven.
Common symptoms of breast implant illness
Symptoms of BII are diverse and can profoundly impact quality of life. The FDA’s analysis of Medical Device Reports (MDRs) highlights the most prevalent issues based on patient submissions:
| Symptom | Percentage of MDRs |
|---|---|
| Fatigue | 41.1% |
| Joint Issues | 30.9% |
| Anxiety | 22.9% |
| Autoimmune diseases | 22.6% |
| Brain Fog | 22.5% |
| Hair Loss | 19.6% |
Additional symptoms from FDA data and patient reports include:
- Depression (16.9%)
- Rash (16.7%)
- Weight changes (16.5%)
- Headaches, muscle pain, insomnia
- Gastrointestinal issues like acid reflux, IBS
- Autoimmune conditions: rheumatoid arthritis, Sjogren’s, Hashimoto’s, lupus
- Respiratory problems, dry eyes/mouth, heart palpitations
Health Canada notes similar patterns, including mood changes, cognitive issues, chronic infections, and skin sensitivities. These align with reports from clinical sites, where patients describe exhaustion, cognitive difficulties, and emotional distress.
Patient stories: ‘I thought I was dying’
Women living with BII often feel dismissed by healthcare providers, turning to social media for validation. Sarah, 42, received implants post-childbirth in 2015. By 2019, debilitating fatigue and joint pain forced her to quit her job. “I couldn’t get out of bed. Doctors blamed perimenopause or depression, but tests were normal,” she shares. After explantation in 2022, her energy returned within months.
Similarly, Lisa, a breast cancer survivor, endured brain fog and rashes after reconstruction. “Reconstruction was supposed to restore normalcy, but it stole my life,” she says. Online forums like Facebook’s 100,000+ member BII groups amplify these voices, fostering community but highlighting diagnostic gaps.
These narratives echo FDA data: symptoms like fatigue dominate reports, with many resolving post-explantation. Yet, skepticism persists, as plastic surgeons often attribute issues to unrelated causes.
Is there a scientific link?
Research on BII is emerging but limited. The FDA has tracked MDRs since 2018, identifying patterns without establishing causality. Studies suggest silicone leakage or bacterial contamination may trigger inflammation via cytokines, leading to fatigue and cognitive impairment.
A 2023 review in peer-reviewed journals links implants to elevated autoimmune risks, though population studies show no overall increase in diseases like rheumatoid arthritis. Critics argue symptoms may stem from nocebo effects or pre-existing conditions. However, explantation yields symptom relief in 90% of cases per some surgeons, warranting further investigation.
BreastCancer.org notes growing reports, urging multidisciplinary approaches. Health Canada monitors via post-market surveillance, emphasizing patient reporting.
Diagnosis and treatment options
No standardized diagnostic test exists for BII; it’s based on symptom clusters post-implantation, excluding other causes. Clinicians recommend:
- Comprehensive bloodwork (thyroid, autoimmune markers)
- Ruling out Lyme, fibromyalgia
- Imaging for implant integrity (MRI for silicone rupture)
Treatment centers on explantation—surgical removal of implants and capsules (en bloc if possible) to eliminate potential triggers. Post-op, patients report gradual improvement: fatigue lifts in 3-6 months, cognitive symptoms in 6-12. Supportive care includes anti-inflammatories, detoxification protocols, and hormone therapy.
Not all improve; some require ongoing management for secondary conditions. Surgeons specializing in BII stress informed consent pre-implantation.
Why the silence? Challenges in recognition
BII’s under-recognition stems from profit-driven aesthetics, limited funding for device studies, and symptom overlap with chronic illnesses. The FDA’s 2020 meeting acknowledged BII but stopped short of formal recognition. Industry lobbying and surgeon incentives delay action.
Women face gaslighting: “It’s in your head” or “Just anxiety.” Advocacy groups push for black-box warnings, similar to textured implant recalls for BIA-ALCL lymphoma.
What should you do if you suspect BII?
- Track symptoms: Log onset relative to implantation.
- Seek specialists: Rheumatologists, BII-aware surgeons.
- Report: To FDA MAUDE database or Health Canada.
- Consider explant: Research “total capsulectomy” experts.
- Support health: Anti-inflammatory diet, exercise, mental health care.
Consult your doctor; do not self-diagnose.
Frequently Asked Questions (FAQs)
Who is at risk for breast implant illness?
Any woman with breast implants—silicone, saline, cosmetic, or reconstructive—regardless of implant characteristics.
Does explantation cure BII?
Many (over 90% in some reports) experience significant relief, but results vary; full recovery can take a year.
Are there tests for BII?
No specific test; diagnosis is clinical after excluding other conditions.
Can BII cause autoimmune diseases?
Reports link it to rheumatoid arthritis, Sjogren’s, etc., but causation unproven.
Should I remove my implants preventively?
Weigh risks/benefits with a doctor; monitoring recommended.
The path forward: Awareness and research
Raising BII awareness empowers women. Patients demand longitudinal studies, implant material reforms, and surgeon education. Until then, listening to those affected is crucial. If you’re struggling, you’re not alone—seek information and support.
References
- Systemic Symptoms in Women with Breast Implants — U.S. Food and Drug Administration. 2023-10-01. https://www.fda.gov/medical-devices/breast-implants/medical-device-reports-systemic-symptoms-women-breast-implants
- Breast Implant Illness Symptoms: What to Know — Tim Sayed MD. 2024-05-15. https://www.timsayedmd.com/breast-implant-illness-symptoms-what-to-know/
- Breast Implant Illness Specialist — Center for Multisystem Disease, Jill R. Schofield, MD. 2024-02-20. https://www.centerformultisystemdisease.com/services/breast-implant-illness
- Breast Implant Illness — Health Canada. 2024-08-12. https://www.canada.ca/en/health-canada/services/drugs-medical-devices/breast-implants/illness.html
- What is Breast Implant Illness (BII)? — BreastCancer.org. 2025-02-01. https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness
Similar Articles
Read full bio of Sneha Tete
